LDHA and hepatocellular carcinoma: Indeed, the results showed that TGF-β1 treatment promoted both primary and secondary spheroid formation ability (Fig. 7F), drug resistance ability (Fig. 7G, Supplementary Fig. 8G), and the ALDH activity (Fig. 7H) in HCC cells.